Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7559979

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
5,280,000 JPY
15,408,000 JPY
2,504,000 JPY
11,300,000 JPY
155,808,000 JPY
Ordinary profit (loss)
-1,473,774,000 JPY
-1,481,945,000 JPY
-1,738,636,000 JPY
-1,823,996,000 JPY
-1,678,084,000 JPY
Profit (loss)
-1,485,633,000 JPY
-1,484,192,000 JPY
-1,719,634,000 JPY
-1,857,774,000 JPY
-1,884,318,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
362,185,000 JPY
6,700,382,000 JPY
6,459,712,000 JPY
5,433,211,000 JPY
5,427,836,000 JPY
Total number of issued shares
62,891,200 xbrli:shares
55,253,100 xbrli:shares
50,817,500 xbrli:shares
42,101,000 xbrli:shares
41,993,500 xbrli:shares
Net assets
1,567,541,000 JPY
2,531,475,000 JPY
3,537,642,000 JPY
3,235,237,000 JPY
5,096,072,000 JPY
Total assets
1,701,444,000 JPY
2,771,202,000 JPY
3,749,428,000 JPY
3,474,639,000 JPY
5,304,463,000 JPY
Net assets per share
24.60
45.40
69.10
75.49
119.66
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-24.90
-28.55
-36.14
-44.20
-44.95
Diluted earnings per share
Equity-to-asset ratio
0.909 xbrli:pure
0.905 xbrli:pure
0.937 xbrli:pure
0.915 xbrli:pure
0.947 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,204,401,000 JPY
-1,512,022,000 JPY
-1,769,848,000 JPY
-1,784,461,000 JPY
-1,457,571,000 JPY
Net cash provided by (used in) investing activities
-1,760,000 JPY
-17,566,000 JPY
-36,211,000 JPY
-106,879,000 JPY
-185,115,000 JPY
Net cash provided by (used in) financing activities
432,104,000 JPY
569,226,000 JPY
2,053,090,000 JPY
8,521,000 JPY
15,810,000 JPY
Cash and cash equivalents
1,530,969,000 JPY
2,305,026,000 JPY
3,265,388,000 JPY
3,018,356,000 JPY
4,901,177,000 JPY
Number of employees
32 xbrli:pure
5 xbrli:pure
38 xbrli:pure
44 xbrli:pure
44 xbrli:pure
42 xbrli:pure
Average number of temporary employees
1 xbrli:pure
6 xbrli:pure
4 xbrli:pure
xbrli:pure
3 xbrli:pure
Total shareholder return
0.214 xbrli:pure
0.128 xbrli:pure
0.242 xbrli:pure
0.270 xbrli:pure
0.383 xbrli:pure
Total return on share price index
0.621 xbrli:pure
0.655 xbrli:pure
0.998 xbrli:pure
0.514 xbrli:pure
0.792 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.